TrialArthritis & rheumatology (Hoboken, N.J.)2024

Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature.

Junjie Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.